Caligor Rx Announces Agreement to Provide Prescription Services to CIGNA Expatriate Customers

- Will Enable CIGNA's Expatriate Customers to Obtain Quality-Assured Prescriptions from Their Home Countries

NEW YORK--(BUSINESS WIRE)-- Caligor Rx, a leading global clinical trial procurement company, today announced an agreement with CIGNA, a world leader in group health benefits for expatriates, to supply prescription medications to CIGNA's expatriate customers.

“We are proud to work with a world-class organization such as CIGNA to provide prescription services to its international members around the world,” said Joseph Safdie, Esq., Caligor Rx’s Vice President and Corporate Counsel. “This agreement highlights the strength of our global pharmaceutical supply business and directly complements our expertise in offering customized solutions, such as unlicensed medicines and expanded access programs, for a range of specialized needs.”

“Our primary objective is to facilitate ease of access to the best available health care services around the world,” said Dr. Daniel Ober, chief medical officer for CIGNA International Expatriate Benefits. “Through Caligor Rx, we are able to ensure our customers who travel abroad will get the highest quality prescription medications available without the worry of counterfeit drugs that have emerged in many locations.”

About CIGNA

CIGNA (NYSE: CI) is a global health service company dedicated to helping people improve their health, well-being and sense of security. CIGNA Corporation's operating subsidiaries in the United States provide an integrated suite of health services, such as medical, dental, behavioral health, pharmacy and vision care benefits, as well as group life, accident and disability insurance. Outside the U.S., CIGNA serves expatriates in virtually every country in the world and provides employers, affinity groups and individuals access to quality local and global health care and related financial protection programs. CIGNA offers products and services in 29 countries and jurisdictions and has more than 66 million customer relationships throughout the world. To learn more about CIGNA, visit www.cigna.com.

About Caligor Rx

Caligor Rx is an international pharmaceutical supply company engaged in efficient, cost-effective sourcing and supply of comparator drugs for clinical trials worldwide. A woman-owned company, Caligor Rx is licensed to distribute approved and unlicensed medicines in the continental United States and throughout Europe. Headquartered in New York City with facilities in Europe, the company's operations include state-of-the-art warehousing and distribution, complete with monitored cold chain and ambient storage capabilities. Caligor Rx’s retail pharmacy, founded in 1919, serves patients, physicians, hospitals and healthcare providers. Information about the company’s services is available at www.caligorrx.com.